1,037 results on '"Molls, Michael"'
Search Results
102. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy
103. Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients
104. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study
105. Disease Presentation and Treatment Outcome in Very Young Patients with Brain Metastases from Lung Cancer
106. Comparison Study of Oxygen-Induced MRI-Signal Changes and pO2 Changes in Murine Tumors
107. Radiotherapy for Pituitary Adenomas
108. Does Prophylactic Breast Irradiation in Patients With Prostate Cancer Influence Cardiac Toxicity?
109. Violated Earth - Violent Earth
110. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas
111. Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents
112. New drugs for BNCT: An experimental approach
113. Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience
114. Influence of different treatment techniques on radiation dose to the LAD coronary artery
115. Radiation Pneumopathy — Experimental and Clinical Data
116. Changes in Head and Neck Tumor Hypoxic Fraction during Split-Course Radiochemotherapy
117. Chromosomal radiosensitivity and acute radiation side effects after radiotherapy in tumour patients - a follow-up study
118. Nachhaltige Entwicklung in Afrika
119. Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas
120. Retreatment of the spinal cord with palliative radiotherapy
121. Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy – a case report
122. Prognostic scores in brain metastases from breast cancer
123. Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?
124. Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines
125. Influence of different treatment techniques on radiation dose to the LAD coronary artery
126. Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors
127. Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer
128. Tumor hypoxia, p53, and prognosis in cervical cancers
129. Tangential Field Radiotherapy for Breast Cancer—The Dose to the Heart and Heart Subvolumes: What Structures Must Be Contoured in Future Clinical Trials?
130. Increased cell survival and cytogenetic integrity by spatial dose redistribution at a compact synchrotron X-ray source
131. First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas
132. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas
133. Der Einfluss von Hypoxie auf die Expression von Komponenten des Plasminogen-Aktivierungs-Systems und den Vascular Endothelial Growth Factor in Plattenepithelkarzinomzelllinien des Kopf-Hals-Bereiches.
134. Zerebrale Kontrolle und Überleben nach stereotaktischer Strahlentherapie von Hirnmetastasen
135. Bestrahlungsinduzierte Regulation des Plasminogenaktivator-Inhibitor Typ 1 (PAI-1) und des vaskulären endothelialen Wachstumsfaktors (VEGF) in sechs Plattenepithelkarzinomzelllinien der Kopf-Hals-Region
136. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer
137. Kontrollrate und Toxizität bei stereotaktischer Zweitbestrahlung von höhergradig-malignen Hirntumoren
138. Der Einfluss intrafraktioneller Bewegungen auf die Zielvolumendefinition in der Strahlentherapie
139. Study of Preoperative Radiotherapy for Sarcomas of the Extremities with Intensity-Modulation, Image-Guidance and Small Safety-margins (PREMISS)
140. Einfluß der Organ-und Patientenbewegungen auf das Zielvolumen bei der Radiotherapie des Prostatakarzinoms
141. Increased cell survival and cytogenetic integrity by spatial dose redistribution at a compact synchrotron X-ray source
142. Tangential Field Radiotherapy for Breast Cancer—The Dose to the Heart and Heart Subvolumes: What Structures Must Be Contoured in Future Clinical Trials?
143. Microbeam radiation therapy at a laser-based compact synchrotron x-ray source
144. Radiochirurgie und stereotaktisch fraktionierte Strahlentherapie am Linearbeschleuniger bei Patienten mit Meningeomen;Wertigkeit der L-[Methyl-11C] Methionin (MET)-PET-Untersuchung als Ergänzung zu morphologischen bildgebenden Verfahren wie CT und MRT bei der Erstellung der Therapieplanung und Definition des Zielvolumens der Schädelbasismeningeome
145. Vergleichende Untersuchung zum Einfluss von Hypoxie auf das Plasminogenaktivierungssystem und den Wachstumsfaktor VEGF in vier Plattenepithelkarzinomzelllinien
146. Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial
147. Auswirkungen von Bestrahlung auf die Expression und Lokalisation von uPA, PAI-1 und VEGF in drei Kopf-Hals-Xenografttumoren
148. Pharmakologische Beeinflussung von strahleninduzierten Nierenfunktionsstörungen
149. Laudationes: Professor Dr. Alfred Breit 75 Jahre
150. Akute Toxizität und Therapieoutcome bei adjuvanter Radiochemotherapie von Patienten mit lokal fortgeschrittenem Kopf-Hals-Tumor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.